Early research (Phase 1)Study completedNCT02771340
What this trial is testing
Study Evaluating Single and Repeated Intravitreal Doses of ICON-1 in Patients With Uveal Melanoma
Who this might be right for
Uveal MelanomaChoroid Neoplasm
Iconic Therapeutics, Inc. 10